Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
anti-LeY- scFv-CD28-ζ vector
i
Other names:
anti-LeY- scFv-CD28-ζ vector, anti-Lewis-Y chimeric antigen receptor, anti-LeY- scFv-CD28- zeta vector, LeY CAR T
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
BMS, Peter MacCallum Cancer Centre
Drug class:
Lewis Y antigen-targeted CAR-T immunotherapy
Related drugs:
‹
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
›
Associations
News
Trials
Filter by
Latest
5ms
A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours (clinicaltrials.gov)
P1, N=20, Completed, Peter MacCallum Cancer Centre, Australia | Active, not recruiting --> Completed
5 months ago
Trial completion • CAR T-Cell Therapy • Metastases
|
cyclophosphamide • anti-LeY- scFv-CD28-ζ vector
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login